ClassID:

20885

A61K38/012 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Hydrolysed proteins; Derivatives thereof from animals

Sub-classes:
Recent Application in this class:
#1
20260048057
2026-02-19

ANTI-ISCHEMIC COMPOSITIONS

#2
20260014103
2026-01-15

COMBINATION REMEDY

#3
20250360173
2025-11-27

EGG ALLERGY PREVENTING AGENT OR THE LIKE, AND FOOD COMPOSITION CONTAINING SAME

#4
20250213660
2025-07-03

Veterinary Composition Comprising Superoxide Dismutase and at Least One Hydrolysate of Proteins Rich in Bioassimilable Peptides

#5
20250213618
2025-07-03

USE OF BOVINE SPLEEN PEPTIDE POWDER IN IMPROVING SLEEP, PREVENTING OR TREATING DEPRESSION, OR IMPROVING INTESTINAL FUNCTION

#6
20250195599
2025-06-19

ANTI-DIABETIC STEROIDAL LACTONES OF WITHANIA COAGULANS FOR TREATMENT OF TYPE 2 DIABETES

#7
20250127853
2025-04-24

METHODS AND COMPOSITIONS FOR REDUCING NEUTROPHILS OR NEUTROPHIL INFILTRATION AT THE SITE OF DISEASE

#8
20250127845
2025-04-24

MEDICINAL USES OF OLIGOPEPTIDES IN COMBINATION WITH AN ANTIANDROGEN

#9
20240382453
2024-11-21

PROTEIN HYDROLYSATES

#10
20240316140
2024-09-26

COMPOSITION FOR LIVER PROTECTION COMPRISING MIXTURE OF PORCINE PLACENTA ENZYMATIC HYDROLYSATE AND ACID HYDROLYSATE

#11
20240261339
2024-08-08

INSECT PROTEIN COMPOSITION FOR THE PREVENTION AND TREATMENT OF CONDITIONS RELATED TO INTESTINAL OXIDATIVE STRESS DAMAGE

#12
20240252413
2024-08-01

Silk Protein Fragment Compositions and Articles Manufactured Therefrom

#13
20240024406
2024-01-25

Pharmaceutical composition for treating, preventing or ameliorating spinal muscular atrophy and administration method thereof

#14
20230321175
2023-10-12

ANTI-DIABETIC STEROIDAL LACTONES OF WITHANIA COAGULANS FOR TREATMENT OF TYPE 2 DIABETES

#15
20230302080
2023-09-28

METHOD FOR PRODUCING A MAMMALIAN BRAIN PROTEIN HYDROLYSATE

#16
20230302078
2023-09-28

METHODS AND COMPOSITIONS FOR WEIGHT CONTROL

#17
20230085841
2023-03-23

Stable silk protein fragment compositions

#18
20230020917
2023-01-19

EGG ALLERGY PREVENTING AGENT OR THE LIKE, AND FOOD COMPOSITION CONTAINING SAME

#19
20220354850
2022-11-10

ANTI-ISCHEMIC COMPOSITIONS

#20
20220332773
2022-10-20

SILK-DERIVED PROTEIN FOR TREATING INFLAMMATION

#21
20220279814
2022-09-08

PROTEIN HYDROLYSATE DERIVED FROM BLUE-BACKED FISH

#22
20220273618
2022-09-01

PROTEIN HYDROLYSATES

#23
20220226223
2022-07-21

Stable silk protein fragment compositions

#24
20220152144
2022-05-19

FOOD ADDITIVE INCLUDING MANNAN OLIGOSACCHARIDES TO ENHANCE ANIMAL PERFORMANCE AND METHOD OF USING THE SAME

#25
20220071933
2022-03-10

COMBINATION REMEDY

#26
20220041671
2022-02-10

MODIFIED LIGAND-GATED ION CHANNELS AND METHODS OF USE

#27
20210403522
2021-12-30

MODIFIED LIGAND-GATED ION CHANNELS AND METHODS OF USE

#28
20210317468
2021-10-14

SYNTHESIS AND STRUCTURE OF HIGH POTENCY RNA THERAPEUTICS

#29
20210252099
2021-08-19

FISH PROTEIN HYDROLYSATE POWDER AND A COMPOSITION COMPRISING SAID POWDER FOR USE AS A MEDICAMENT

#30
20210145037
2021-05-20

PROTEIN HYDROLYSATE FOR SHORT TERM RENAL FUNCTIONING

#31
20210128640
2021-05-06

HYALURONIC ACID PRODUCTION PROMOTING AGENT

#32
20210015885
2021-01-21

Small molecule Ras inhibitors

#33
20210008174
2021-01-14

Veterinary Composition Comprising Superoxide Dismutase and at Least One Hydrolysate of Proteins Rich in Bioassimilable Peptides

#34
20200377566
2020-12-03

Modified ligand-gated ion channels and methods of use

#35
20200188269
2020-06-18

Stable silk protein fragment compositions

#36
20200188268
2020-06-18

Stable silk protein fragment compositions

#37
20190381078
2019-12-19

Performance food product

#38
20190380944
2019-12-19

Stable silk fibroin based pharmaceutical formulations

#39
20190375807
2019-12-12

Modified ligand-gated ion channels and methods of use

#40
20190336431
2019-11-07

Stable silk fibroin based pharmaceutical formulations

#41
20190169243
2019-06-06

Silk-derived protein for treating inflammation

#42
20190099520
2019-04-04

REINFORCED TISSUE MATRICES

#43
20190070089
2019-03-07

Stable silk fibroin based pharmaceutical formulations

#44
20190070088
2019-03-07

SILK PROTEIN FRAGMENT COMPOSITIONS AND ARTICLES MANUFACTURED THEREFROM

#45
20190062439
2019-02-28

ST2L antagonists and methods of use

#46
20190002906
2019-01-03

Synthesis and structure of high potency RNA therapeutics

#47
20180371038
2018-12-27

NOVEL PROTEINS SPECIFIC FOR PYOVERDINE AND PYOCHELIN

#48
20180371037
2018-12-27

NOVEL PROTEINS SPECIFIC FOR PYOVERDINE AND PYOCHELIN

#49
20180360903
2018-12-20

Peptide having highly-shifted accumulation to pancreatic cancer cells and tissues, and use of said peptide

#50
20180346532
2018-12-06

NOVEL PROTEINS SPECIFIC FOR PYOVERDINE AND PYOCHELIN

#51
20180117094
2018-05-03

Egg chalaza hydrolysate, method for preparing the same and usage of the same

#52
20180086799
2018-03-29

Proteins specific for pyoverdine and pyochelin

#53
20180037619
2018-02-08

Proteins specific for pyoverdine and pyochelin

#54
20180037618
2018-02-08

Proteins specific for pyoverdine and pyochelin

#55
20180036350
2018-02-08

Hyaluronic acid production promoting agent

#56
20180030101
2018-02-01

Proteins specific for pyoverdine and pyochelin

#57
20180028593
2018-02-01

TERMINAL NANOFILTRATION OF SOLUBILIZED PROTEIN COMPOSITIONS FOR REMOVAL OF IMMUNOGENIC AGGREGATES

#58
20180009862
2018-01-11

Modified ligand-gated ion channels and methods of use

#59
20180008678
2018-01-11

Preparation method of albumin peptide combination having the action of inhibiting the proliferation of cancer cells

#60
20170304383
2017-10-26

Small molecule Ras inhibitors

#61
20170304240
2017-10-26

Compounds supports hematopoietic stem cells and red blood cells

#62
20170267734
2017-09-21

Proteins specific for pyoverdine and pyochelin

#63
20170266249
2017-09-21

METHODS AND COMPOSITIONS FOR WEIGHT CONTROL

#64
20170258866
2017-09-14

Marine peptides and nucleotides

#65
20170107264
2017-04-20

Freeze-dried powder of high molecular weight silk fibroin, preparation method therefor and use thereof

#66
20170066831
2017-03-09

ST2L antagonists and methods of use

#67
20160193130
2016-07-07

Stable silk protein fragment compositions

#68
20160143319
2016-05-26

Performance food product

#69
20160038569
2016-02-11

Particles containing a growth factor, and uses thereof

#70
20160022563
2016-01-28

Stable silk protein fragment compositions

#71
20160022562
2016-01-28

Stable silk protein fragment compositions

#72
20160022561
2016-01-28

Stable silk protein fragment compositions

#73
20160022560
2016-01-28

Stable silk protein fragment compositions

#74
20150259411
2015-09-17

Nucleic acid encoding anti-IL13 human antibodies

#75
20150224178
2015-08-13

Powdered milk product and method for producing the same

#76
20150190547
2015-07-09

Bone matrix compositions and methods

#77
20150164973
2015-06-18

Chondrocyte proliferation promoting agent

#78
20150094269
2015-04-02

Silk protein fragment compositions and articles manufactured therefrom

#79
20150093340
2015-04-02

Stable silk protein fragment compositions

#80
20150072929
2015-03-12

Pharmaceutical composition comprising a mixture of carboxylated oligopeptides

#81
20150072925
2015-03-12

Methods for weight loss and ketogenic compositions

#82
20150025001
2015-01-22

FISH PROTEIN HYDROLYSATE HAVING A SATIETOGENIC ACTIVITY, NUTRACEUTICAL AND PHARMACOLOGICAL COMPOSITIONS COMPRISING SUCH A HYDROLYSATE AND METHOD FOR OBTAINING SAME

#83
20140221293
2014-08-07

Fish protein hydrolysate having a bone-stimulating and maintaining activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same

#84
20130337076
2013-12-19

Particles containing a growth factor, and uses thereof

#85
20130336980
2013-12-19

ST2L antibody antagonists

#86
20130287777
2013-10-31

ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions

#87
20130209497
2013-08-15

Whole egg protein peptides, preparation method and use thereof

#88
20130045915
2013-02-21

Method for weight loss and ketogenic compositions

#89
20120197003
2012-08-02

Modified oligopeptides for the treatment of pancreatitis, stomach ulcers, and other hyperenzymemias based on enzyme peptide inhibitors and methods for obtaining them

#90
20120129787
2012-05-24

Modified oligopeptides with anticancer properties and methods of obtaining them

#91
20120108508
2012-05-03

Method for promoting secretion of glucagon-like peptide-1 by administering κ-casein

#92
20120083450
2012-04-05

CEREBROPROTEIN HYDROLYSATE FOR TREATING BRAIN INJURIES AND NEURODEGENERATIVE CONDITIONS EFFECTING THE BRAIN

#93
20120077747
2012-03-29

FISH-DERIVED PROTEIN LYSATE, AND USES THEREOF AS IMMUNOMODULATORY AND/OR ANTI-INFLAMMATORY AGENT

#94
20110257094
2011-10-20

Anti periodontitis-causing microorganism agent and medical or dental materials using the same

#95
20110124570
2011-05-26

FISH PROTEIN HYDROLYSATE HAVING A BONE-STIMULATING AND MAINTAINING ACTIVITY, NUTRACEUTICAL AND PHARMACOLOGICAL COMPOSITIONS COMPRISING SUCH A HYDROLYSATE AND METHOD FOR OBTAINING SAME

#96
20110111031
2011-05-12

Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof

#97
20110091458
2011-04-21

Method of using anti-IL-13 antibodies

#98
20110052695
2011-03-03

DRUG DELIVERY PLATFORMS COMPRISING SILK FIBROIN HYDROGELS AND USES THEREOF

#99
20110039768
2011-02-17

FISH PROTEIN HYDROLYSATE HAVING A SATIETOGENIC ACTIVITY, NUTRACEUTICAL AND PHARMACOLOGICAL COMPOSITIONS COMPRISING SUCH A HYDROLYSATE AND METHOD FOR OBTAINING SAME,

#100
20100255039
2010-10-07

INDUCTION OF TOLERANCE TO EGG PROTEINS

#101
20100189709
2010-07-29

ELASTASE INHIBITOR

#102
20100144638
2010-06-10

Method for inhibiting postprandial rise in blood glucose by administering κ-casein

#103
20100087851
2010-04-08

Methods and compositions for sealing and adhering biological tissues and medical uses thereof

#104
20100035810
2010-02-11

Adiponectin production enhancer

#105
20090324777
2009-12-31

METHOD OF PRODUCING A PALATABILITY ENHANCER THAT CAN ADD HEALTH VALUE TO FOODSTUFFS

#106
20090311236
2009-12-17

Therapeutic Peptide Compositions And Methods Of Making And Using Same

#107
20090175828
2009-07-09

Coagulation factor X polypeptides with modified activation properties

#108
20090131316
2009-05-21

GLUCAGON-LIKE PEPTIDE-1 SECRETAGOGUE, GLUCAGON-LIKE PEPTIDE-1 SECRETAGOGUE FOOD OR DRINK, INHIBITOR OF POSTPRANDIAL RISE IN BLOOD GLUCOSE, AND INHIBITORY FOOD OR DRINK OF POSTPRANDIAL RISE IN BLOOD GLUCOSE

#109
20090029005
2009-01-29

Anti-hypertensive functional food products

#110
20080292750
2008-11-27

Method of Preparing a Food Ingredient and Food Product Having Angiotensin-I-Converting Enzyme Inhibiting Properties and Products Thus Obtained

#111
20080267959
2008-10-30

Anti-IL13 human antibodies

#112
20080249639
2008-10-09

Medical Artificial Nerve Graft Containing Silk Fibroin and Its Preparation Method

#113
20080248014
2008-10-09

Animal Medicament and Method of Manufacture

#114
20080108549
2008-05-08

Actin proteins as biomarkers for indication and targeting of resistance and sensitivity to an Abl kinase inhibitor in patients with chronic myelogenous leukemia

#115
20070191282
2007-08-16

Composition for suppressing re-elevation of cholesterol, and usage thereof

#116
20070142274
2007-06-21

Fish protein hydrolyzate

#117
20070141044
2007-06-21

Method for treating cancer patients undergoing chemotherapy

#118
20070116659
2007-05-24

ELASTASE INHIBITOR

#119
20070110820
2007-05-17

Bone matrix compositions and methods

#120
20070098756
2007-05-03

Bone matrix compositions and methods

#121
20070087968
2007-04-19

Methods to treat T-cell disorders using TISF

#122
20070026045
2007-02-01

Reinforced matrices

#123
20060280804
2006-12-14

Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis

#124
20050265946
2005-12-01

Elastase inhibitor

#125
20050101523
2005-05-12

Amino acids from fish and soy proteins improve insulin sensitivity

#126
20050074423
2005-04-07

Cosmetic composition containing oyster flash enzymatic hydrolysates